Cargando…
The difference of the inflammatory milieu in MIS-C and severe COVID-19
BACKGROUND: Coronavirus disease 19 (COVID-19) may have a severe course in children. Multisystem inflammatory syndrome in children (MIS-C) is the post-COVID complication characterized by an exaggerated inflammation, observed in children. However, data on the underlying pathophysiology are sparse. We...
Autores principales: | Gurlevik, Sibel Lacinel, Ozsurekci, Yasemin, Sağ, Erdal, Derin Oygar, P., Kesici, Selman, Akca, Ümmüşen Kaya, Cuceoglu, Muserref Kasap, Basaran, Ozge, Göncü, Sultan, Karakaya, Jale, Cengiz, Ali Bülent, Özen, Seza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963396/ https://www.ncbi.nlm.nih.gov/pubmed/35352005 http://dx.doi.org/10.1038/s41390-022-02029-4 |
Ejemplares similares
-
The Effect of Biologics in the Treatment of Multisystem Inflammatory Syndrome in Children (Mis-C): A Single-Center Propensity-Score-Matched Study †
por: Basaran, Ozge, et al.
Publicado: (2023) -
Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases
por: Kaya Akca, Ummusen, et al.
Publicado: (2021) -
Favipiravir use in children with COVID-19 and acute kidney injury: is it safe?
por: Ozsurekci, Yasemin, et al.
Publicado: (2021) -
Correction to: Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean
por: Ozsurekci, Yasemin, et al.
Publicado: (2021) -
Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean
por: Ozsurekci, Yasemin, et al.
Publicado: (2021)